Article History
Accepted: 24 October 2019
First Online: 17 December 2019
Competing interests
: R.J.B. receives royalties and grant support from JUNO Therapeutics and is a consultant for JUNO Therapeutics/Celgene. The other authors declare no competing interests.
Free to read: This content has been made available to all.